MAIA Biotechnology, Inc.
MAIA
$1.12
-$0.06-5.09%
AMEX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 46.15% | -7.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 81.20% | -4.78% | |||
| Operating Income | -81.20% | 4.78% | |||
| Income Before Tax | -66.51% | -18.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -66.51% | -18.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -66.51% | -18.37% | |||
| EBIT | -81.20% | 4.78% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -51.95% | -8.22% | |||
| Normalized Basic EPS | -51.95% | -8.24% | |||
| EPS Diluted | -51.95% | -8.22% | |||
| Normalized Diluted EPS | -51.95% | -8.24% | |||
| Average Basic Shares Outstanding | 9.58% | 9.40% | |||
| Average Diluted Shares Outstanding | 9.58% | 9.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||